发明名称 |
Therapeutic method for mesothelioma |
摘要 |
The present invention relates to a therapeutic method and a diagnostic method using an antibody that binds to a ganglioside GM2 antigen, and a therapeutic agent and a diagnostic agent comprising as an active ingredient an antibody that binds to a ganglioside GM2 antigen. According to the present invention, the prognosis of GM2 positive mesothelioma patients can be improved by diagnosing and treating GM2 positive mesothelioma patients with a diagnostic agent and a therapeutic agent that comprise an anti-ganglioside GM2 antibody as an active ingredient. |
申请公布号 |
US9066929(B2) |
申请公布日期 |
2015.06.30 |
申请号 |
US201314097294 |
申请日期 |
2013.12.05 |
申请人 |
NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY;KYOWA HAKKO KIRIN CO., LTD. |
发明人 |
Yano Seiji;Machino Yusuke;Suzuki Yui |
分类号 |
A61K39/395;G01N33/574;A61K45/06;C07K16/18 |
主分类号 |
A61K39/395 |
代理机构 |
Sughrue Mion, PLLC |
代理人 |
Sughrue Mion, PLLC |
主权项 |
1. A method for treating mesothelioma, comprising administering as an active ingredient an antibody or a fragment thereof that binds to a ganglioside GM2 into a subject in need thereof,
wherein the antibody comprises heavy chain (H-chain) complementarity determining regions (CDRs) 1 to 3 having the amino acid sequences of SEQ ID NOS: 1 to 3, respectively, and light chain (L-chain) CDRs 1 to 3 having the amino acid sequences of SEQ ID NOS: 4 to 6, respectively. |
地址 |
Kanazawa-shi JP |